2919976-92-2
Chemical Structure
CXJ-2
- CAS No.: 2919976-92-2
- Formula:C55H87N15O22
- Molecular Weight:1310.37
IUPAC Name: 3,3'-((6S,9S,12S,15S,18S,21S,24S,26aS,32S,38R,41S,44S,46aS)-18-(3-amino-3-oxopropyl)-38-ethyl-6,24,32-tris(hydroxymethyl)-41-isopropyl-9,21,38,44-tetramethyl-5,8,11,14,17,20,23,26,31,34,37,40,43,46-tetradecaoxohexatetracontahydrodipyrrolo[1,2-a:1',2'-s][1,4,7,10,13,16,19,22,25,28,31,34,37,40]tetradecaazacyclodotetracontine-12,15-diyl)dipropionic acid
InChIKey: IWEVNELPRMMTLS-XBDMQZQESA-N
SMILES: O=C([C@@H](NC1=O)C(C)C)N[C@](CC)(C(NCC(N[C@H](C(N2[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N3[C@H](C(N[C@H]1C)=O)CCC3)=O)CO)=O)C)=O)CCC(O)=O)=O)CCC(O)=O)=O)CCC(N)=O)=O)C)=O)CO)=O)CCC2)=O)CO)=O)=O)C
Biological Activity: CXJ-2 is a cyclic peptide, and exhibits moderate affinity toward elastin derived peptides (EDPs). CXJ-2 exhibits potent activities to inhibit the PI3K/ERK pathway and decrease hepatic stellate cell proliferation and migration. CXJ-2 possesses potent antifibrotic efficacy[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CXJ-2 | CXJ-2 is a cyclic peptide, and exhibits moderate affinity toward elastin derived peptides (EDPs). CXJ-2 exhibits potent activities to inhibit the PI3K/ERK pathway and decrease hepatic stellate cell proliferation and migration. CXJ-2 possesses potent antifibrotic efficacy. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
